A possible explanation of this resistance may rely in the fact that there is no gain of function of TP53 protein that is essential for AML cell survival; TP53 loss generates an identical phenotype when compared with TP53 mutations and the molecular alteration stay—in fact—undruggable (72). The gene discussed is TP53; the disease is acute myeloid leukemia.